Run-Long Medtech Raises in Extended Series A Round from Apricot Capital

(VCBeat) Apr. 19, 2021 -- Recently, Run-Long Medtech, a leading sports medicine company in China, announced that it has completed an additional Series A round of financing worth nearly 100 million yuan. Gelu Capital has continuously acted as the exclusive financial adviser. This funding round is less than half a year away from the last round of Run-Long Medtech, with participation from the existing investor Apricot Capital. The funds raised will mainly be used for product R&D and market expansion.

Run-Long Medtech is an innovative medical device company focusing on the field of sports medicine in the domestic high-end market. The company takes "guided by the demands of patients, volunteer to be a partner of doctors" as its responsibility. It is committed to building a leading brand of high-end medical devices, continuously breaking through international technological monopoly by product innovation, and take a leap in the period of "replacement of imported products" in the sports med medical device industry.

At the beginning of 2021, Run-Long Medtech obtained the registration certificate of four products, including "Radio-Frequency Plasma Cutter Head". Up to now, Run-Long Medtech has held more than ten registration certificates approved by NMPA, which further enriches the product line of the company. The approval of Radio-Frequency Plasma Cutter Head" means that Run-Long Medtech has completed the product layout in the two fields of shaver blades and low-temperature plasma radiofrequency, fully covering the field of sports medicine cleaning and surgical consumables.

Relying on high-performance products, brand and resource advantages, Run-Long Medtech has achieved rapid growth in sales performance. The average monthly sales in 2021 have reached three times the level of the same period last year.

Apricot Capital is an investment firm focused on investing in companies in the early and growth stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.

Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in the healthcare industry. Its professional background includes life sciences, medicine, finance and law.